Male hormonal contraception: Potential risks and benefits

被引:0
|
作者
Niloufar Ilani
Ronald S. Swerdloff
Christina Wang
机构
[1] Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute,Division of Endocrinology, Department of Medicine
[2] General Clinical Research Center,undefined
[3] Harbor-UCLA Medical Center,undefined
关键词
Testosterone; Progestin; Male contraception; Family planning;
D O I
暂无
中图分类号
学科分类号
摘要
An effective, safe, reversible, and acceptable method of contraception is an important component of reproductive health and provides the opportunity of shared responsibility for family planning for both partners. Female hormonal contraceptives have been proven to be safe, reversible, available and widely acceptable by different populations. In contrast, male hormonal contraception, despite significant progress showing contraceptive efficacy comparable to female hormonal methods during last three decades, has not yet led to an approved product. Safety of a pharmaceutical product is an appropriate concern but the majority of male hormonal contraceptive clinical trials have not reported significant short term safety concerns. While the absence of serious adverse effects is encouraging, the studies have been designed for efficacy endpoints not long term safety. In this review we summarize potential risks and benefits of putative male hormonal contraceptives on reproductive and non-reproductive organs. While the review covers what we believe will be the likely class of drugs used for male hormonal contraception a true assessment of long term risks and benefits cannot be achieved without an available product.
引用
收藏
相关论文
共 50 条
  • [21] Towards male hormonal contraception
    Hargreave, TB
    [J]. NEW HORIZONS IN REPRODUCTIVE MEDICINE, 1997, 12 : 99 - 105
  • [22] Advances in male hormonal contraception
    Anawalt, BD
    Amory, JK
    [J]. ANNALS OF MEDICINE, 2001, 33 (09) : 587 - 595
  • [23] Advances in male hormonal contraception
    Antonietta, Costantino
    Giulia, Gava
    Marta, Berra
    Cristina, Meriggiola Maria
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2014, 140 : 58 - 62
  • [24] Advances in male hormonal contraception
    Meriggiola, MC
    Pelusi, G
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (04) : 389 - 397
  • [25] The struggle for male hormonal contraception
    Nieschlag, Eberhard
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 25 (02) : 369 - 375
  • [26] Update on male hormonal contraception
    Gava, Giulia
    Meriggiola, Maria Cristina
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2019, 10 : 1 - 9
  • [27] ORAL CONTRACEPTION - BENEFITS AND RISKS
    BRAENDLE, W
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1995, 257 (1-4) : 532 - 536
  • [28] Risks and benefits of adolescent contraception
    Dexeus, S
    Martinez, F
    [J]. CONTRACEPTION TODAY, 1997, 14 : 204 - 212
  • [29] Non contraceptive benefits of hormonal contraception
    Szarewski, A
    [J]. HUMAN REPRODUCTION, 2005, : 722 - 727
  • [30] HORMONAL CONTRACEPTIVES - BENEFITS AND RISKS
    BRECKWOLDT, M
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1989, 49 (06) : 521 - 522